Literature DB >> 20582746

Effects of ketamine added to ropivacaine in pediatric caudal block.

Ramazan Odeş1, Omer Lütfi Erhan, Muhammed Demirci, Hülya Göksu.   

Abstract

OBJECTIVES: We aimed to determine the hemodynamic effects and postoperative pain control quality of ropivacaine and ketamine addition to ropivacaine in children undergoing inguinal hernia repair with caudal anesthesia.
METHODS: A total of 45 patients (1-4 years) scheduled to undergo inguinal hernia repair were studied. Anesthesia was induced with sevoflurane in O2/N2O and vecuronium was administered to facilitate endotracheal intubation. Anesthesia was maintained with sevoflurane in O2/N2O. Patients were randomly divided into three groups. Following endotracheal intubation, we administered 2 mg/kg 0.2% ropivacaine to Group R; 0.5 mg/kg ketamine to Group K; and 2 mg/kg 0.2% ropivacaine plus 0.5 mg/kg ketamine to Group R+K caudally. Pain levels were evaluated via modified CHEOPS, and sedation levels were assessed by the Wilson Sedation Scale.
RESULTS: At the postoperative 45th minute (min), the CHEOPS score was significantly higher in Group R compared to Group K and Group R+K (p<0.05). This score was significantly higher in Group R than in Group R+K at the postoperative 60th min (p<0.05). The effective analgesic period was significantly higher in Group K (852+/-309 min) and Group R+K (1032+/-270 min) than in Group R (435.5+/-273 min) (p<0.05). The analgesic requirement in the first 24 hours postoperatively was lower in Group R+K than the other groups. Sedation scores were below 2 in all groups. There were no significant differences between groups regarding adverse events.
CONCLUSION: The results of the present study indicate that caudal ropivacaine, ketamine and ropivacaine plus ketamine provided effective postoperative analgesia. Additionally, ketamine combined with ropivacaine lengthened the duration of analgesia while lowering analgesic requirements.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20582746

Source DB:  PubMed          Journal:  Agri        ISSN: 1300-0012


  7 in total

1.  Comparing caudal and intravenous ketamine for supplementation of analgesia after Salter innominate osteotomy.

Authors:  Hamid Reza Amiri; Ramin Espandar; Mehdi Sanatkar
Journal:  J Child Orthop       Date:  2012-11-16       Impact factor: 1.548

Review 2.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

3.  Topical versus caudal ketamine/bupivacaine combination for postoperative analgesia in children undergoing inguinal herniotomy.

Authors:  Hala Saad Abdel-Ghaffar; Seham Mohamed Moeen; Ahmed Mohamed Moeen
Journal:  Saudi J Anaesth       Date:  2017 Jan-Mar

4.  Subcutaneous ketamine prolongs the analgesic effect of local infiltration of plain Bupivacaine in children undergoing inguinal herniotomy.

Authors:  Alex Oham; Ifeoma Ekwere; Kingsley Tobi
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

Review 5.  Review of clinical evidence of caudal block for postoperative analgesia in children with ketamine added local anesthetics.

Authors:  Amanuel Sisay Endeshaw; Esubalew Muluneh Aligaz; Misganew Terefe Molla; Befekadu Amare Mekonnen; Abdi Tariku Tesema; Tesfaye Abebe Dinku; Kirubel Behailu Atero; Tsion Lemma Regassa
Journal:  Ann Med Surg (Lond)       Date:  2022-03-08

Review 6.  Analgesic Efficacy of Adjuvant Medications in the Pediatric Caudal Block for Infraumbilical Surgery: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Ushma J Shah; Niveditha Karuppiah; Hovhannes Karapetyan; Janet Martin; Herman Sehmbi
Journal:  Cureus       Date:  2022-08-30

7.  Effect of caudal ketamine on minimum local anesthetic concentration of ropivacaine in children: a prospective randomized trial.

Authors:  Huai-Zhen Wang; Ling-Yu Wang; Hui-Hong Liang; Yan-Ting Fan; Xing-Rong Song; Ying-Jun She
Journal:  BMC Anesthesiol       Date:  2020-06-08       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.